Influenza A (H1N1) 2009 pandemic virus: Learning from the first wave, preparing for the second

Medical Journal of Malaysia

Volumn 65, Issue 1, 2010, Pages 1-2

  Lee, Christopher K C ^a  

^a HOSPITAL SUNGAI BULOH   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; SWINE INFLUENZA VACCINE;

DRUG SAFETY; EDITORIAL; HEALTH EDUCATION; HOST PATHOGEN INTERACTION; HUMAN; INFECTION CONTROL; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; NONHUMAN; PANDEMIC INFLUENZA; PUBLIC HEALTH PROBLEM; SEASONAL INFLUENZA; VACCINE PRODUCTION; VIRUS VIRULENCE; WINTER;

HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; PANDEMICS; TIME FACTORS;

EID: 77958062875     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (7)

1. Taubenberger JK: The origin and virulence of the 1918 "Spanish" influenza virus. Proc Am Philos Soc 2006; 150: 86-112.
2. Tumpey TM, Maines TR et al: A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 2007; 315: 655-59.
3. Morens DM, Taubenberger JK: Understanding influenza backwards. JAMA 2009; 302: 679-80.
4. WHO Pandemic (H1N1) briefing note 12; 25th September 2009.
5. WHO Guidance Document: Pandemic Influenza Peparedness and Response. April 2009.
6. Safety of Influenza A (H1N1) 2009 Monovalent Vaccines - United States October 1 - November 24, 2009. Morbidity and Mortality Weekly Report (MMWR) December 4 2009; 58: 1-6.
7. Providing a safer environment for healthcare personnel and patients immunization and vaccination: Strategies for Research and Practice. http:/WWW.jointcommision.org/PatientSafety/InfectionControl/flu-mon ograph.htm